An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA offered an accelerated approval path.

Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this ...

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

G-CSF Limitations: These agents essentially overstimulate a bone marrow that is already damaged by chemotherapy. Furthermore, while they address neutrophils, they do not mitigate damage to platelets ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital has secured a £110,000 grant from Orthopaedic Research UK to ...

Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...

The thing about cancer is that the treatments, and choosing to go through them, is hard; you must endure what feels like ...

Christina Merrill, the founder and CEO at the Bone Marrow & Cancer Foundation, is hoping to foster community and connection ...